Oppenheimer & Co’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-1,116
| Closed | -$3K | – | 1354 |
|
|
2018
Q4 | $3K | Sell |
1,116
-400
| -26% | -$1.08K | ﹤0.01% | 1236 |
|
|
2018
Q3 | $11K | Sell |
1,516
-880
| -37% | -$6.39K | ﹤0.01% | 1342 |
|
|
2018
Q2 | $19K | Sell |
2,396
-1,955
| -45% | -$15.5K | ﹤0.01% | 1319 |
|
|
2018
Q1 | $152K | Sell |
4,351
-40
| -0.9% | -$1.4K | ﹤0.01% | 1257 |
|
|
2017
Q4 | $188K | Buy |
4,391
+391
| +10% | +$16.7K | ﹤0.01% | 1219 |
|
|
2017
Q3 | $172K | Sell |
4,000
-2,396
| -37% | -$103K | ﹤0.01% | 1198 |
|
|
2017
Q2 | $237K | Sell |
6,396
-329
| -5% | -$12.2K | 0.01% | 1111 |
|
|
2017
Q1 | $364K | Sell |
6,725
-1,114
| -14% | -$60.3K | 0.01% | 924 |
|
|
2016
Q4 | $417K | Sell |
7,839
-1,300
| -14% | -$69.2K | 0.01% | 871 |
|
|
2016
Q3 | $554K | Sell |
9,139
-2,085
| -19% | -$126K | 0.02% | 771 |
|
|
2016
Q2 | $739K | Sell |
11,224
-2,139
| -16% | -$141K | 0.02% | 644 |
|
|
2016
Q1 | $758K | Sell |
13,363
-374
| -3% | -$21.2K | 0.02% | 616 |
|
|
2015
Q4 | $3.23M | Buy |
13,737
+2,013
| +17% | +$473K | 0.1% | 243 |
|
|
2015
Q3 | $1.85M | Buy |
11,724
+275
| +2% | +$43.5K | 0.06% | 385 |
|
|
2015
Q2 | $4.33M | Sell |
11,449
-916
| -7% | -$347K | 0.12% | 198 |
|
|
2015
Q1 | $5.17M | Sell |
12,365
-1,492
| -11% | -$624K | 0.14% | 171 |
|
|
2014
Q4 | $3.79M | Sell |
13,857
-2,902
| -17% | -$794K | 0.11% | 222 |
|
|
2014
Q3 | $3.26M | Buy |
16,759
+1,225
| +8% | +$238K | 0.1% | 250 |
|
|
2014
Q2 | $3.8M | Buy |
15,534
+3,002
| +24% | +$735K | 0.11% | 212 |
|
|
2014
Q1 | $3.32M | Buy |
12,532
+5,377
| +75% | +$1.43M | 0.1% | 247 |
|
|
2013
Q4 | $2.6M | Sell |
7,155
-50
| -0.7% | -$18.2K | 0.08% | 295 |
|
|
2013
Q3 | $3.83M | Sell |
7,205
-727
| -9% | -$386K | 0.13% | 195 |
|
|
2013
Q2 | $1.86M | Buy |
+7,932
| New | +$1.86M | 0.07% | 321 |
|